Supplementary Figure S2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas

Valeriya Pankova; Lukáš Krásný; William Kerrison; Yuen B. Tam; Madhumeeta Chadha; Jessica Burns; Christopher P. Wilding; Liang Chen; Avirup Chowdhury; Emma Perkins; Alexander T.J. Lee; Louise Howell; Nafia Guljar; Karen Sisley; Cyril Fisher; Priya Chudasama; Khin Thway; Robin L. Jones; Paul H. Huang

doi:10.1158/1078-0432.26423177

Abstract

Supplementary Figure S2. Validation of MMP14 expression in undifferentiated pleomorphic sarcoma (UPS), dedifferentiated liposarcoma (DDLPS) and leiomyosarcoma (LMS) by immunohistochemistry (IHC).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pankova et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574ccd https://doi.org/10.1158/1078-0432.26423177

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure S2. Validation of MMP14 expression in undifferentiated pleomorphic sarcoma (UPS), dedifferentiated liposarcoma (DDLPS) and leiomyosarcoma (LMS) by immunohistochemistry (IHC).

Supplementary Figure S2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas

Abstract

Discussion

Cite This Study

Supplementary Figure S2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas

Abstract

Discussion

Cite This Study

Keep reading

Keep reading